These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31883461)

  • 1. Prepubertal Bleeding as a Presenting Symptom of Von Willebrand Disease: A Case Report.
    Chambers C; Adeyemi-Fowode O
    J Pediatr Adolesc Gynecol; 2020 Apr; 33(2):167-169. PubMed ID: 31883461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Von Willebrand's disease: case report and review of literature.
    Echahdi H; El Hasbaoui B; El Khorassani M; Agadr A; Khattab M
    Pan Afr Med J; 2017; 27():147. PubMed ID: 28904675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical diagnosis of von Willebrand disease.
    Federici AB
    Haemophilia; 2004 Oct; 10 Suppl 4():169-76. PubMed ID: 15479393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal angiodysplasia and bleeding in von Willebrand disease.
    Franchini M; Mannucci PM
    Thromb Haemost; 2014 Sep; 112(3):427-31. PubMed ID: 24898873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Von Willebrand disease presenting as recurrent hemorrhage after transvaginal oocyte retrieval.
    Moayeri SE; Coutre SE; Ramirez EJ; Westphal LM
    Am J Obstet Gynecol; 2007 Apr; 196(4):e10-1. PubMed ID: 17403383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing bleeding in von Willebrand disease with bleeding score.
    Tosetto A; Castaman G; Rodeghiero F
    Blood Rev; 2007 Mar; 21(2):89-97. PubMed ID: 16774804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet von Willebrand factor determination does not improve the diagnosis of patients with suspected Type 1 von Willebrand disease.
    Shihong I; Morris D; Konkle BA
    Haemophilia; 2009 Jan; 15(1):131-4. PubMed ID: 18976254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).
    Nichols WL; Hultin MB; James AH; Manco-Johnson MJ; Montgomery RR; Ortel TL; Rick ME; Sadler JE; Weinstein M; Yawn BP
    Haemophilia; 2008 Mar; 14(2):171-232. PubMed ID: 18315614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
    Dean JA; Blanchette VS; Carcao MD; Stain AM; Sparling CR; Siekmann J; Turecek PL; Lillicrap D; Rand ML
    Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. von Willebrand disease: a clinical and laboratory study of sixty-five patients.
    Chen YC; Yang L; Cheng SN; Hu SH; Chao TY
    Ann Hematol; 2011 Oct; 90(10):1183-90. PubMed ID: 21643680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and treatment of von Willebrand disease.
    Cox Gill J
    Hematol Oncol Clin North Am; 2004 Dec; 18(6):1277-99, viii. PubMed ID: 15511616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Droplet-Shaped Deep Intraretinal Hemorrhage as Initial Presentation of Von Willebrand Disease Type 1.
    Lin HT; Chang YH
    Ophthalmic Surg Lasers Imaging Retina; 2016 Nov; 47(11):1044-1048. PubMed ID: 27842199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory diagnosis of von Willebrand disease.
    Roberts JC; Flood VH
    Int J Lab Hematol; 2015 May; 37 Suppl 1(Suppl 1):11-7. PubMed ID: 25976955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. State of the art: von Willebrand disease.
    James AH; Eikenboom J; Federici AB
    Haemophilia; 2016 Jul; 22 Suppl 5():54-9. PubMed ID: 27405677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a von Willebrand factor three test panel and chemiluminescent-based assay system for identification of, and therapy monitoring in, von Willebrand disease.
    Favaloro EJ; Mohammed S
    Thromb Res; 2016 May; 141():202-11. PubMed ID: 26743192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis and management of von Willebrand disease].
    Higasa S; Tokugawa T; Sawada A
    Rinsho Ketsueki; 2018; 59(10):2222-2232. PubMed ID: 30305529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired von Willebrand syndrome: diagnostic problems and therapeutic options.
    Eikenboom JC; Tjernberg P; Van Marion V; Heering KJ
    Am J Hematol; 2007 Jan; 82(1):55-8. PubMed ID: 16986130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline factor VIII plasma levels and age at first bleeding in patients with severe forms of von Willebrand disease.
    Siboni SM; Biguzzi E; Caiani V; Mistretta C; Bucciarelli P; Peyvandi F
    Haemophilia; 2016 Jul; 22(4):564-9. PubMed ID: 26843468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.